12:00 AM
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Deals

Astex Pharmaceuticals, Eisai deal

Astex received a $5 million milestone payment from Eisai triggered by the first commercial sale of cancer drug Dacogen decitabine in the EU. Astex will receive royalties starting at...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >